Promising prebiotic candidate established by evaluation of lactitol, lactulose, raffinose, and oligofructose for maintenance of a Lactobacillus-dominated vaginal microbiota

Applied and Environmental Microbiology

Volumn 84, Issue 5, 2018, Pages

  Collins, Stephanie L ^a,b   McMillan, Amy ^a,b,h   Seney, Shannon ^b   van der Veer, Charlotte ^c   Kort, Remco ^d,e,f   Sumarah, Mark W ^g   Reid, Gregor ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^c DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e TNO   (Netherlands)

^f Micropia   (Netherlands)

^g AGRICULTURE AND AGRI FOOD CANADA   (Canada)

^h LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Bacterial vaginosis; Lactitol; Lactobacilli; Lactulose; Oligofructose; Prebiotics; Raffinose; Vaginal microbiota

Indexed keywords

ANTIMICROBIAL AGENTS; BACILLI; BIOLOGY; CANDIDA; HEALTH; LACTIC ACID;

BACTERIAL VAGINOSIS; LACTITOL; LACTOBACILLI; LACTULOSE; MICROBIOTAS; OLIGO-FRUCTOSE; PREBIOTICS; RAFFINOSE;

BACTERIA;

BACTERIAL DISEASE; BACTERIUM; COLONIZATION; INGESTION RATE; MICROBIAL COMMUNITY; MONOCULTURE; REPRODUCTIVE HEALTH; SPECIES DIVERSITY; SUGAR; WOMENS HEALTH;

BACTERIA (MICROORGANISMS); CANDIDA ALBICANS; LACTOBACILLUS; LACTOBACILLUS CRISPATUS; LACTOBACILLUS GASSERI; LACTOBACILLUS INERS; LACTOBACILLUS JENSENII; LACTOBACILLUS JOHNSONII; LACTOBACILLUS VAGINALIS;

BACTERIAL RNA; LACTITOL; OLIGOSACCHARIDE; PREBIOTIC AGENT; RNA 16S; SUGAR ALCOHOL;

DRUG EFFECT; DYSBIOSIS; FEMALE; GENETICS; HUMAN; LACTOBACILLUS; MASS SPECTROMETRY; METABOLOMICS; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY; PROCEDURES; SEQUENCE ANALYSIS; VAGINA;

DYSBIOSIS; FEMALE; HUMANS; LACTOBACILLUS; MASS SPECTROMETRY; METABOLOMICS; MICROBIOTA; OLIGOSACCHARIDES; PREBIOTICS; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, RNA; SUGAR ALCOHOLS; VAGINA;

EID: 85041993601     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.02200-17     Document Type: Article

References (59)

1. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SSK, McCulle SL, Karlebach S, Gorle R, Russell J, Tacket CO, Brotman RM, Davis CC, Ault K, Peralta L, Forney LJ. 2011. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A 108:4680-4687. https://doi.org/10 .1073/pnas.1002611107
2. Reid G, Younes JA, Van der Mei HC, Gloor GB, Knight R, Busscher HJ. 2011. Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat Rev Microbiol 9:27-38. https://doi .org/10.1038/nrmicro2473
3. Reid G, Brigidi P, Burton JP, Contractor N, Duncan S, Fargier E, Hill C, Lebeer S, Martín R, McBain AJ, Mor G, O'Neill C, Rodríguez JM, Swann J, van Hemert S, Ansell J. 2015. Microbes central to human reproduction. Am J Reprod Immunol 73:1-11. https://doi.org/10.1111/aji.12319
4. Hummelen R, Fernandes AD, Macklaim JM, Dickson RJ, Changalucha J, Gloor GB, Reid G. 2010. Deep sequencing of the vaginal microbiota of women with HIV. PLoS One 5:e12078. https://doi.org/10.1371/journal .pone.0012078
5. Dols JAM, Smit PW, Kort R, Reid G, Schuren FHJ, Tempelman H, Bontekoe TR, Korporaal H, Boon ME. 2011. Microarray-based identification of clinically relevant vaginal bacteria in relation to bacterial vaginosis. Am J Obstet Gynecol 204:305.e1-305.e7. https://doi.org/10.1016/j.ajog.2010 .11.012
6. McMillan A, Rulisa S, Sumarah M, Macklaim JM, Renaud J, Bisanz JE, Gloor GB, Reid G. 2015. A multi-platform metabolomics approach identifies highly specific biomarkers of bacterial diversity in the vagina of pregnant and non-pregnant women. Sci Rep 5:14174. https://doi.org/10.1038/ srep14174
7. Ness RB, Kip KE, Hillier SL, Soper DE, Stamm CA, Sweet RL, Rice P, Richter HE. 2005. A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am J Epidemiol 162:585-590. https:// doi.org/10.1093/aje/kwi243
8. Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, Chohan B, Mandaliya K, Ndinya-Achola JO, Bwayo J, Kreiss J. 1999. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 180:1863-1868. https://doi.org/10.1086/315127
9. Wiesenfeld HC, Hillier SL, Krohn MA, Landers DV, Sweet RL. 2003. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis 36:663-668. https://doi.org/ 10.1086/367658
10. Redondo-Lopez V, Meriwether C, Schmitt C, Opitz M, Cook R, Sobel JD. 1990. Vulvovaginal candidiasis complicating recurrent bacterial vaginosis. Sex Transm Dis 17:51-53. https://doi.org/10.1097/00007435-199001000-00011
11. Koumans EH, Sternberg M, Bruce C, McQuillan G, Kendrick J, Sutton M, Markowitz LE. 2007. The prevalence of bacterial vaginosis in the United States, 2001-2004: associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis 34:864-869. https://doi.org/10 .1097/OLQ.0b013e318074e565
12. Oleen-Burkey MA, Hillier SL. 1995. Pregnancy complications associated with bacterial vaginosis and their estimated costs. Infect Dis Obstet Gynecol 3:149-157. https://doi.org/10.1155/S1064744995000500
13. Fischbach F, Petersen EE, Weissenbacher ER, Martius J, Hosmann J, Mayer H. 1993. Efficacy of clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol 82: 405-410
14. Bradshaw CS, Morton AN, Hocking J, Garland SM, Morris MB, Moss LM, Horvath LB, Kuzevska I, Fairley CK. 2006. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 193: 1478-1486. https://doi.org/10.1086/503780
15. Gajer P, Brotman RM, Bai G, Sakamoto J, Schutte UME, Zhong X, Koenig SSK, Fu L, Ma Z, Zhou X, Abdo Z, Forney LJ, Ravel J. 2012. Temporal dynamics of the human vaginal microbiota. Sci Transl Med 4:132ra52. https://doi.org/10.1126/scitranslmed.3003605
16. Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, Bruce AW. 2003. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebocontrolled trial in 64 healthy women. FEMS Immunol Med Microbiol 35:131-134. https://doi.org/10.1016/S0928-8244(02)00465-0
17. Anukam K, Osazuwa E, Ahonkhai I, Ngwu M, Osemene G, Bruce AW, Reid G. 2006. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect 8:1450-1454. https://doi.org/ 10.1016/j.micinf.2006.01.003
18. Macklaim JM, Clemente JC, Knight R, Gloor GB, Reid G. 2015. Changes in vaginal microbiota following antimicrobial and probiotic therapy. Microb Ecol Health Dis 26:27799. https://doi.org/10.3402/mehd.v26.27799
19. Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, Scott K, Stanton C, Swanson KS, Cani PD, Verbeke K, Reid G. 2017. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 14:491-502. https:// doi.org/10.1038/nrgastro.2017.75
20. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, Wolvers D, Watzl B, Szajewska H, Stahl B, Guarner F, Respondek F, Whelan K, Coxam V, Davicco M-J, Léotoing L, Wittrant Y, Delzenne NM, Cani PD, Neyrinck AM, Meheust A. 2010. Prebiotic effects: metabolic and health benefits. Br J Nutr 104:S1-S63. https://doi.org/10 .1017/S0007114510003363
21. Reid G, Bruce AW, Taylor M. 1995. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol Ther 23:32-45
22. Coste I, Judlin P, Lepargneur J-P, Bou-Antoun S. 2012. Safety and efficacy of an intravaginal prebiotic gel in the prevention of recurrent bacterial vaginosis: a randomized double-blind study. Obstet Gynecol Int 2012: 147867. https://doi.org/10.1155/2012/147867
23. Rousseau V, Lepargneur JP, Roques C, Remaud-Simeon M, Paul F. 2005. Prebiotic effects of oligosaccharides on selected vaginal lactobacilli and pathogenic microorganisms. Anaerobe 11:145-153. https://doi.org/10 .1016/j.anaerobe.2004.12.002
24. Vongsa R, Minerath R, Busch M, Tan J, Koenig D. 2016. In vitro evaluation of nutrients that selectively confer a competitive advantage to lactobacilli. Benef Microbes 7:299-304. https://doi.org/10.3920/BM2015.0047
25. Tester R, Al-Ghazzewi F, Shen N, Chen Z, Chen F, Yang J, Zhang D, Tang M. 2012. The use of konjac glucomannan hydrolysates to recover healthy microbiota in infected vaginas treated with an antifungal agent. Benef Microbes 3:61-66. https://doi.org/10.3920/BM2011.0021
26. Sutherland A, Tester R, Al-Ghazzewi F, McCulloch E, Connolly M. 2008. Glucomannan hydrolysate (GMH) inhibition of Candida albicans growth in the presence of Lactobacillus and Lactococcus species. Microb Ecol Health Dis 20:127-134. https://doi.org/10.1080/08910600802355726
27. Foxman B, Wen A, Srinivasan U, Goldberg D, Marrs CF, Owen J, Wing DA, Misra D. 2014. Mycoplasma, bacterial vaginosis-associated bacteria BVAB3, race, and risk of preterm birth in a high-risk cohort. Am J Obstet Gynecol 210:226.e1-226.e7. https://doi.org/10.1016/j.ajog.2013.10.003
28. Marrazzo JM, Fiedler TL, Srinivasan S, Thomas KK, Liu C, Ko D, Xie H, Saracino M, Fredricks DN. 2012. Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis. J Infect Dis 205: 1580-1588. https://doi.org/10.1093/infdis/jis242
29. Hilbert DW, Smith WL, Chadwick SG, Toner G, Mordechai E, Adelson ME, Sobel JD, Gygax SE. 2016. Development and validation of a highly accurate quantitative real-time PCR assay for the diagnosis of bacterial vaginosis. J Clin Microbiol 54:1017-1024. https://doi.org/10.1128/JCM .03104-15
30. Machado A, Jefferson KK, Cerca N. 2013. Interactions between Lactobacillus crispatus and bacterial vaginosis (BV)-associated bacterial species in initial attachment and biofilm formation. Int J Mol Sci 14:12004-12012. https://doi.org/10.3390/ijms140612004
31. O'Hanlon DE, Moench TR, Cone RA. 2013. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota. PLoS One 8:e80074. https://doi.org/10.1371/journal.pone.0080074
32. O'Hanlon DE, Moench TR, Cone RA. 2011. In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide. BMC Infect Dis 11:200. https://doi.org/10 .1186/1471-2334-11-200
33. Boskey ER, Telsch KM, Whaley KJ, Moench TR, Cone RA. 1999. Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect Immun 67:5170-5175
34. Yeoman CJ, Thomas SM, Miller MEB, Ulanov AV, Torralba M, Lucas S, Gillis M, Cregger M, Gomez A, Ho M, Leigh SR, Stumpf R, Creedon DJ, Smith MA, Weisbaum JS, Nelson KE, Wilson BA, White BA. 2013. A multi-omic systems-based approach reveals metabolic markers of bacterial vaginosis and insight into the disease. PLoS One 8:e56111. https:// doi.org/10.1371/journal.pone.0056111
35. Alakomi H-L, Skyttä E, Saarela M, Mattila-Sandholm T, Latva-Kala K, Helander IM. 2000. Lactic acid permeabilizes Gram-negative bacteria by disrupting the outer membrane. Appl Environ Microbiol 66:2001-2005. https://doi.org/10.1128/AEM.66.5.2001-2005.2000
36. Aldunate M, Tyssen D, Johnson A, Zakir T, Sonza S, Moench T, Cone R, Tachedjian G. 2013. Vaginal concentrations of lactic acid potently inactivate HIV. J Antimicrob Chemother 68:2015-2025. https://doi.org/10 .1093/jac/dkt156
37. Hernandez-Hernandez O, Muthaiyan A, Moreno FJ, Montilla A, Sanz ML, Ricke SC. 2012. Effect of prebiotic carbohydrates on the growth and tolerance of Lactobacillus. Food Microbiol 30:355-361. https://doi.org/ 10.1016/j.fm.2011.12.022
38. Mao B, Li D, Zhao J, Liu X, Gu Z, Chen YQ, Zhang H, Chen W. 2014. In vitro fermentation of lactulose by human gut bacteria. J Agric Food Chem 62:10970-10977. https://doi.org/10.1021/jf503484d
39. Hopkins MJ, Cummings JH, Macfarlane GT. 1998. Inter-species differ-ences in maximum specific growth rates and cell yields of bifidobacteria cultured on oligosaccharides and other simple carbohydrate sources. J Appl Microbiol 85:381-386. https://doi.org/10.1046/j.1365-2672.1998.00524.x
40. Douillard FP, Ribbera A, Kant R, Pietilä TE, Järvinen HM, Messing M, Randazzo CL, Paulin L, Laine P, Ritari J, Caggia C, Lähteinen T, Brouns SJJ, Satokari R, von Ossowski I, Reunanen J, Palva A, de Vos WM. 2013. Comparative genomic and functional analysis of 100 Lactobacillus rhamnosus strains and their comparison with strain GG. PLoS Genet 9:e1003683. https://doi.org/10.1371/journal.pgen.1003683
41. Larsson P-G, Stray-Pedersen B, Ryttig KR, Larsen S. 2008. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Womens Health 8:3. https://doi.org/ 10.1186/1472-6874-8-3
42. Petrova MI, Reid G, Vaneechoutte M, Lebeer S. 2017. Lactobacillus iners: friend or foe? Trends Microbiol 25:182-191. https://doi.org/10.1016/j.tim .2016.11.007
43. Dirkx M, Boyer MP, Pradhan P, Brittingham A, Wilson WA. 2014. Expression and characterization of a β-fructofuranosidase from the parasitic protist Trichomonas vaginalis. BMC Biochem 15:12. https://doi.org/10 .1186/1471-2091-15-12
44. Roberfroid MB, Loo JAEV, Gibson GR. 1998. The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr 128:11-19
45. Eschenbach DA, Thwin SS, Patton DL, Hooton TM, Stapleton AE, Agnew K, Winter C, Meier A, Stamm WE. 2000. Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clin Infect Dis 30: 901-907. https://doi.org/10.1086/313818
46. Bailey JV, Farquhar C, Owen C. 2004. Bacterial vaginosis in lesbians and bisexual women. Sex Transm Dis 31:691-694. https://doi.org/10.1097/ 01.olq.0000143093.70899.68
47. Liu CM, Hungate BA, Tobian AAR, Ravel J, Prodger JL, Serwadda D, Kigozi G, Galiwango RM, Nalugoda F, Keim P, Wawer MJ, Price LB, Gray RH. 2015. Penile microbiota and female partner bacterial vaginosis in Rakai, Uganda. mBio 6:e00589-15. https://doi.org/10.1128/mBio.00589-15
48. Kort R. 2014. Personalized therapy with probiotics from the host by TripleA. Trends Biotechnol 32:291-293. https://doi.org/10.1016/j.tibtech .2014.04.002
49. Dols JAM, Molenaar D, van der Helm JJ, Caspers MPM, de Kat Angelino-Bart A, Schuren FHJ, Speksnijder AGCL, Westerhoff HV, Richardus JH, Boon ME, Reid G, de Vries HJC, Kort R. 2016. Molecular assessment of bacterial vaginosis by Lactobacillus abundance and species diversity. BMC Infect Dis 16:180. https://doi.org/10.1186/s12879-016-1513-3
50. Nugent RP, Krohn MA, Hillier SL. 1991. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 29:297-301
51. Geshnizgani AM, Onderdonk AB. 1992. Defined medium simulating genital tract secretions for growth of vaginal microflora. J Clin Microbiol 30:1323-1326
52. Aitchison J. 1982. The statistical analysis of compositional data. J R Stat Soc 44:139-177
53. Lopes dos Santos Santiago G, Tency I, Verstraelen H, Verhelst R, Trog M, Temmerman M, Vancoillie L, Decat E, Cools P, Vaneechoutte M. 2012. Longitudinal qPCR study of the dynamics of L. crispatus, L. iners, A. vaginae, (sialidase positive) G. vaginalis, and P. bivia in the vagina. PLoS One 7:e45281. https://doi.org/10.1371/journal.pone.0045281
54. De Backer E, Verhelst R, Verstraelen H, Alqumber MA, Burton JP, Tagg JR, Temmerman M, Vaneechoutte M. 2007. Quantitative determination by real-time PCR of four vaginal Lactobacillus species, Gardnerella vaginalis and Atopobium vaginae indicates an inverse relationship between L. gasseri and L. iners. BMC Microbiol 7:115. https://doi.org/10.1186/1471-2180-7-115
55. Ellison SL, English CA, Burns MJ, Keer JT. 2006. Routes to improving the reliability of low level DNA analysis using real-time PCR. BMC Biotechnol 6:33. https://doi.org/10.1186/1472-6750-6-33
56. Stein SE. 1999. An integrated method for spectrum extraction and compound identification from gas chromatography/mass spectrometry data. J Am Soc Mass Spectrom 10:770-781. https://doi.org/10.1016/ S1044-0305(99)00047-1
57. Styczynski MP, Moxley JF, Tong LV, Walther JL, Jensen KL, Stephanopoulos GN. 2007. Systematic identification of conserved metabolites in GC/MS data for metabolomics and biomarker discovery. Anal Chem 79:966-973. https://doi.org/10.1021/ac0614846
58. Kessner D, Chambers M, Burke R, Agus D, Mallick P. 2008. ProteoWizard: open source software for rapid proteomics tools development. Bioinformatics 24:2534-2536. https://doi.org/10.1093/bioinformatics/btn323
59. Patti GJ, Tautenhahn R, Siuzdak G. 2012. Meta-analysis of untargeted metabolomic data from multiple profiling experiments. Nat Protoc 7:508-516. https://doi.org/10.1038/nprot.2011.454